Bionano Genomics' GAAP loss for 3 months of 2022 was $29.952 million, a three-fold increase from $9.947 million in the previous year. Revenue increased 79.8% to $5.696 million from $3.168 million a year earlier.
Bionano Genomics' GAAP loss for 3 months of 2022 was $29.952 million, a three-fold increase from $9.947 million in the previous year. Revenue increased 79.8% to $5.696 million from $3.168 million a year earlier. 
ir.bionanogenomics.com
English (US) 